18 July 2018 I Half-Year Financial Report 1-6/2018 and related materials are published. View CEO's webcast presentation or have a look at Orion's latest investor slide set.
|9/19/2018||Changes in responsibility areas of the Orion Group Executive Management Board|
|7/18/2018||Orion Group Half-Year Financial Report January-June 2018|
|7/18/2018||Orion Corporation's financial reporting and Annual General Meeting in 2019|
|4/24/2018||Orion Group Interim Report January-March 2018|
|9/17/2018||Creation of novel medicines and better patient care for the future in an ecosystem|
|9/10/2018||Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation|
|7/6/2018||Orion has started a Phase III trial to develop a drug for ALS - The patient recruitment has begun|
|7/5/2018||Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018|
Orion's key research projects include three ongoing Phase III trials, among others.
The Closing of the transaction took place on 30 April 2018.
Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.
The 2018 Annual General Meeting of Orion was held on Tuesday, 20 March 2018 in Helsinki.
The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.